• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑热病后皮肤利什曼病:黑热病控制项目中被忽视的一个方面。

Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.

作者信息

Thakur C P, Kumar K

机构信息

Department of Medicine and Dermatology, Patna Medical College Hospital, India.

出版信息

Ann Trop Med Parasitol. 1992 Aug;86(4):355-9. doi: 10.1080/00034983.1992.11812678.

DOI:10.1080/00034983.1992.11812678
PMID:1463355
Abstract

Post kala-azar dermal leishmaniasis (PKDL) was studied in relation to the kala-azar epidemic in Bihar, India. Between 1970 and 1989, 530 individuals, 302 males and 228 females, were admitted to the hospital of Patna Medical College with PKDL, the number of cases steadily rising from two in 1970 to 59 in 1989. The age of the patients varied from four to 70 years, with 33% aged 11-20 years and 16% 0-10 years. The prevalence of kala-azar in India also increased in the same period, mostly as the result of an epidemic of the disease in Bihar. There were no cases of this disease admitted to Patna Medical College from 1958-1970, it having become rare in India in the 1950s, possibly as a result of the DDT sprayed during the National Malaria Eradication Programme. In the period 1977-1990, however, there were 301,076 cases of kala-azar reported in Bihar alone, with a mortality rate over 2% (compared with 31,074 cases and a mortality rate below 0.4% for the rest of India). It seems possible that, once DDT spraying stopped, the re-establishment of large sandfly population and infection of these vectors, largely as a result of them feeding on cases of PKDL, provoked the resurgence of kala-azar. The study emphasizes the need to search for cases of PKDL, even in young children, and to monitor and effectively treat them as part of kala-azar control programmes. All patients could be cured if treated with the right dosage for the right period.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在印度比哈尔邦,对黑热病后皮肤利什曼病(PKDL)与黑热病流行的关系进行了研究。1970年至1989年期间,530名患者(302名男性和228名女性)因PKDL入住巴特那医学院医院,病例数从1970年的2例稳步上升至1989年的59例。患者年龄在4岁至70岁之间,其中33%年龄在11 - 20岁,16%年龄在0 - 10岁。同期印度黑热病的患病率也有所上升,主要是由于比哈尔邦该病的流行。1958年至1970年期间,巴特那医学院没有收治过这种疾病的病例,20世纪50年代它在印度已变得罕见,可能是由于全国疟疾根除计划期间喷洒了滴滴涕。然而,在1977年至1990年期间,仅比哈尔邦就报告了301,076例黑热病病例,死亡率超过2%(相比之下,印度其他地区为31,074例,死亡率低于0.4%)。一旦停止喷洒滴滴涕,大量白蛉种群的重新建立以及这些媒介的感染,很大程度上是因为它们吸食PKDL患者的血液,这似乎可能引发了黑热病的再度流行。该研究强调,即使是幼儿,也需要寻找PKDL病例,并将对其监测和有效治疗作为黑热病控制计划的一部分。如果给予正确的剂量并在正确的时期进行治疗,所有患者都可以治愈。(摘要截选至250字)

相似文献

1
Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.黑热病后皮肤利什曼病:黑热病控制项目中被忽视的一个方面。
Ann Trop Med Parasitol. 1992 Aug;86(4):355-9. doi: 10.1080/00034983.1992.11812678.
2
Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.两性霉素B治疗黑热病对印度比哈尔邦皮肤利什曼病发病率的影响。
Indian J Med Res. 2008 Jul;128(1):38-44.
3
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
4
Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states.印度晚期内脏利什曼病后皮肤利什曼病(PKDL)临床流行病学变化:在四个流行地区的调查结果。
J Vector Borne Dis. 2020 Apr-Jun;57(2):161-169. doi: 10.4103/0972-9062.310875.
5
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.通过在印度比哈尔邦实施基于卫生机构的哨点监测系统,改善黑热病病例管理。
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009598. doi: 10.1371/journal.pntd.0009598. eCollection 2021 Aug.
6
Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis.苏丹东部的地方性黑热病:黑热病后皮肤利什曼病
Am J Trop Med Hyg. 1995 Apr;52(4):299-305. doi: 10.4269/ajtmh.1995.52.299.
7
Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).比哈尔邦黑热病(包括黑热病后皮肤利什曼病)的流行病学、临床及治疗特征
Trans R Soc Trop Med Hyg. 1984;78(3):391-8. doi: 10.1016/0035-9203(84)90131-7.
8
Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.在孟加拉国的一项基于人群的研究中,黑热病后皮肤利什曼病的发病率不断增加。
Clin Infect Dis. 2010 Jan 1;50(1):73-6. doi: 10.1086/648727.
9
Epidemiology of visceral leishmaniasis in India.印度内脏利什曼病的流行病学
Natl Med J India. 1999 Mar-Apr;12(2):62-8.
10
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.苏丹的黑热病后皮肤利什曼病:临床表现与鉴别诊断
Br J Dermatol. 2000 Jul;143(1):136-43. doi: 10.1046/j.1365-2133.2000.03603.x.

引用本文的文献

1
Post kala-azar dermal leishmaniasis: A threat to elimination program.无鞭毛体利什曼原虫病皮肤后:消除规划的威胁。
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul.
2
Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.穆扎法普尔健康和人口监测点的黑热病后皮肤利什曼病和麻风病的患病率和分布情况。
PLoS Negl Trop Dis. 2019 Oct 25;13(10):e0007798. doi: 10.1371/journal.pntd.0007798. eCollection 2019 Oct.
3
Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection.
米替福新耐药印度黑热病患者分离株在实验感染中表现出相似表型。
Sci Rep. 2017 Sep 4;7(1):10330. doi: 10.1038/s41598-017-09720-1.
4
Recent developments and future prospects in the treatment of visceral leishmaniasis.内脏利什曼病治疗的最新进展与未来前景
Ther Adv Infect Dis. 2016 Jun;3(3-4):98-109. doi: 10.1177/2049936116646063. Epub 2016 Apr 22.
5
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.印度次大陆内脏利什曼病的传播动力学——一项系统文献综述
PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug.
6
Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis.巴龙霉素治疗黑热病后皮肤利什曼病的疗效与安全性
ISRN Parasitol. 2014 Mar 6;2014:548010. doi: 10.1155/2014/548010. eCollection 2014.
7
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.血清ADA活性升高作为印度患者内脏利什曼病和黑热病后皮肤利什曼病诊断及预后标志物
PLoS One. 2016 May 17;11(5):e0154117. doi: 10.1371/journal.pone.0154117. eCollection 2016.
8
The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice.免疫刺激复合物(ISCOMATRIX)双层成分在诱导BALB/c小鼠细胞介导的免疫反应及预防利什曼病方面的作用。
Iran J Basic Med Sci. 2016 Feb;19(2):178-86.
9
Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.一些2,3-二取代-4(3H)-喹唑啉酮衍生物的合成及其抗利什曼原虫活性评价
Org Med Chem Lett. 2014 Dec;4(1):10. doi: 10.1186/s13588-014-0010-1. Epub 2014 Sep 17.
10
Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.印度黑热病后皮肤利什曼病(PKDL)病例与治疗相关的临床病理和免疫学变化:一项回顾性研究。
Biomed Res Int. 2015;2015:745062. doi: 10.1155/2015/745062. Epub 2015 May 18.